Curbside Consults

Cardiovascular and Renal Outcomes in Type 2 Diabetes Medications with Dr. Marie McDonnell

04.17.2019 - By NEJM GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

The number of medications available to treat diabetes continues to increase. Recently, there has been widespread interest in two classes of medications, the SGLT2 inhibitors and the GLP1 agonists. They have created quite the splash with improvements in cardiovascular outcomes in patients with type 2 diabetes. In this podcast...

More episodes from Curbside Consults